{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:38:17Z","timestamp":1775615897446,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijcard.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T22:02:36Z","timestamp":1594850556000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction"],"prefix":"10.1016","volume":"321","author":[{"given":"Mohammad","family":"Alkhalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"MacElhatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Fergie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.07.001_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0010","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0015","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.07.001_bb0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjcard.2017.04.005","article-title":"Prognostic implications of mid-range left ventricular ejection fraction on patients presenting with ST-segment elevation myocardial infarction","volume":"120","author":"Margolis","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","article-title":"Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction","volume":"4","author":"Kapoor","year":"2016","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0030","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ejhf.159","article-title":"The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%)","volume":"16","author":"Lam","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jchf.2016.03.025","article-title":"Understanding heart failure with mid-range ejection fraction","volume":"4","author":"Lam","year":"2016","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0040","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCULATIONAHA.117.027324","article-title":"Fussing over the middle child: heart failure with mid-range ejection fraction","volume":"135","author":"Lam","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.07.001_bb0045","first-page":"112","article-title":"Flow, reflected by stroke volume index, is a risk marker in high-gradient aortic stenosis patients undergoing transcatheter aortic valve replacement","volume":"36","author":"Alkhalil","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0050","article-title":"Clinical outcomes of deferred revascularisation using fractional flow reserve in diabetic patients","volume":"2019","author":"Alkhalil","year":"2017","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2005.01.041","article-title":"Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score","volume":"45","author":"Halkin","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modelling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat. Med."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/00015385.2018.1501140","article-title":"In-hospital and long-term prognoses of patients with a mid-range ejection fraction after an ST-segment myocardial infarction","volume":"74","author":"Karabag","year":"2019","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0075","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jacc.2006.06.075","article-title":"Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study","volume":"48","author":"Ikeda","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0080","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.110.959734","article-title":"Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks","volume":"123","author":"Goldberger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.07.001_bb0085","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/ehz260","article-title":"Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study","volume":"40","author":"Gatzoulis","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0090","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2020.07.001_bb0095","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril cardiac evaluation (TRACE) study group","volume":"333","author":"Kober","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2020.07.001_bb0105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0110","first-page":"599","article-title":"Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study","volume":"8","author":"Montenegro Sa","year":"2019","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.ijcard.2020.07.001_bb0115","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"Beta-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1753944718809266","article-title":"The effect of angiotensin-converting enzyme inhibitors on clinical outcomes in patients with ischemic cardiomyopathy and midrange ejection fraction: a post hoc subgroup analysis from the PEACE trial","volume":"12","author":"Alzahrani","year":"2018","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0125","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/clc.23261","article-title":"Eplerenone in patients with myocardial infarction and \"mid-range\" ejection fraction: an analysis from the EPHESUS trial","volume":"42","author":"Ferreira","year":"2019","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0130","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.07.001_bb0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320334495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320334495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:48:41Z","timestamp":1759092521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320334495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":27,"alternative-id":["S0167527320334495"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.07.001","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}